# Safety Evaluation of Use Sodic Enoxaparin

> **NCT00673426** · PHASE3 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 60 (actual)

## Conditions studied

- Kidney Disease

## Interventions

- **BIOLOGICAL:** Enoxaparin sodic

## Key facts

- **NCT ID:** NCT00673426
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-03
- **Final completion:** 2008-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2008-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673426, "Safety Evaluation of Use Sodic Enoxaparin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00673426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*